Study of the VIVO ISAR Stent in Heart Patients
Part of Heart & circulation clinical trials.
This registry tracks people who get a VIVO ISAR stent to see how well it works and how safe it is. If you have a stent placed and take blood thinners for three months or less, you might be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You can only have the VIVO ISAR stent placed (no other types of stents at the same time).
- You plan to take anti-clotting medication for 3 months or less after the procedure.
- You cannot be pregnant.
- You must not have had a stroke in the last 6 months.
- You cannot have another heart procedure with a stent in the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing how well the Vivo ISAR stent works in everyday medical practice for people with different types of heart disease. It is for patients who need a stent for blocked arteries and are willing to receive only the Vivo ISAR stent.
This study is tracking how well a specific stent (GORE® VIABAHN® VBX) works over time in people who need treatment for narrowed or blocked blood vessels. It aims to see if the stent helps keep blood flowing long-term.
This study follows people who already had a stent put in (PCI) using a special imaging test (NIRS-IVUS) to look at heart outcomes over time. If you agreed and can attend follow-up visits, this registry may help doctors better understand how this imaging-guided approach performs.
This study follows people who need a coronary (heart) stent to see how they do after treatment. It does not sound like an experimental drug trial for you—it’s mainly about collecting health information after a stent procedure.
This trial tests whether implanting stents in non-obstructive, high-risk plaques (thin-capped fatty plaques) can prevent future heart attacks. It is for people who have already had treatment for a recent heart attack or unstable angina and have additional plaques that are not severely blocking blood flow but are vulnerable.
This trial tests whether using computer software to virtually plan stent placement before your heart procedure leads to better outcomes. The goal is to optimize how stents are positioned in your coronary arteries.
Hear when a new Cardiovascular Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.